← Back to Search

Vitamin

Hydroxocobalamin for Vasoplegic Syndrome

Phase 2
Waitlist Available
Led By James A. Nelson, M.B.B.S.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights

Summary

This study is evaluating whether a medication may help improve blood pressure for individuals who have had heart surgery.

Eligible Conditions
  • Vasoplegic Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Mean Arterial Pressure
Secondary outcome measures
Change in Norepinephrine Equivalent Infusion Rate. Norepinephrine Equivalent Table is Listed in the Study Protocol
Change in Systolic Blood Pressure
Death
+2 more

Side effects data

From 2024 Phase 4 trial • 19 Patients • NCT04054999
11%
Surgical and medical procedures - Other.
100%
80%
60%
40%
20%
0%
Study treatment Arm
Cyanokit
Methylene Blue

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: B12aExperimental Treatment2 Interventions
Subjects will receive Hydroxocobalamin marketed as Cyanokit®, 5g, IV
Group II: PlaceboPlacebo Group2 Interventions
Subjects will receive placebo
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Hydroxocobalamin
FDA approved

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,255 Previous Clinical Trials
3,835,398 Total Patients Enrolled
1 Trials studying Vasoplegic Syndrome
19 Patients Enrolled for Vasoplegic Syndrome
James A. Nelson, M.B.B.S.Principal Investigator - Mayo Clinic
Mayo Clinic Health System-Mankato, St. James Medical Center-Mayo Health System
~1 spots leftby Jul 2025